Draft ibuprofen 200 - 800 mg oral use, immediate release formulations product-specific bioequivalence guidance

  • Email
  • Help

Document details

Download document Draft ibuprofen 200 - 800 mg oral use, immediate release formulations product-specific bioequivalence guidance
Reference number EMA/CHMP/356876/2017
Status draft: consultation open
First published 2017-08-03
Last updated 2017-08-03
Consultation start date 2017-08-03
Consultation end date 2017-10-31
Email address for submissions pkwpsecretariat@ema.europa.eu

Summary

This document provides product-specific guidance on the demonstration of the bioequivalence of ibuprofen